![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, June 22, 2020 7:14:14 PM
So let me give you a practical perspective of why this most likely be IMO a game changer. In the 30+ years in practice I met with scores of Pharma reps in my office. I attended many medical conventions for CE credit and the conventions of Pharma vendors from L.A, Las Vegas, Paris, Milan, Vienna and far more that is not necessary to mention. In all those years I have yet to have a rep say we have a drug that will cure a disease that you have seen in your practice. But they ALL have touted a drug that will treat that disease they had mentioned. Sorry for this long diatribe and I'll come to the point now. Big Pharma does not want to cure disease. There is no money or profits to me made for that endpoint. That being said, the money is in treating the disease in a therapeutic modality. Ergo, Brilacidin! Treatment is where Pharma makes their profits, not cures. It's sad, but true and that is the reality of pharmaceutical industry. So I would love to see B used in conjunction for other drugs for a vaccine. But for us investors in IPIX the money will be in the Tx of Covid19 which we are perfectly positioned at this time. IMO this is the game changer the world is looking for. I can't even give a wild guess how many different drugs I had to us on patients when they no longer were viable because of drug resistance. It was like a dog chasing his tail. That, however, will not be the case with a defensin mimetic drug such as B. And therein lies one part of the miraculous genesis of this class of drug. And Covid19 is just a drop in the bucket of the possibilities of the cadre of scientist that will utilize the stable of drugs and their uses. Crohn's, OM, Cancer, etc with K and endless other uses that we probably haven't envisioned at this date with skyrocket IPIX's value. IMO it's not a question of "if", but when this will see not only double digit dollars, but it's not a stretch to see IPIX in triple digit dollar pps. As they say in Disneyland please keep you arms and legs inside the car during the ride. Because we are in for a wild ride very soon as we reach dizzying heights of profitability. And my personal thx to all the wonderful contributors that have supplied such wonderful and insightful technical and informative information. There are too many to mention here. And ironically I give thx to the FUD-sters and Mako type posters that enabled me to add hundred of thousands of shares that I never could afforded in the $3 ranges of the past. To use a classic metaphor, I, as well as other longs have made lemonade out of the lemons we had been handed these past few years. All the best to all.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM